Discover 707 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 707
Activity for Diabetic Polyneuropathy
for
Diabetic Neuropathy
Location: Kansas City KS, Salt Lake City UT
Sponsor: Virginia Commonwealth University
Sex: All
Age: 30 - 70+
Code: NCT02341261
Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
for
Degenerative Disc Disease, Disc Degeneration,
Location: Kansas City KS, Shreveport LA, Tyler TX, New Castle IN,
Sponsor: VIVEX Biologics, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06778447
Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
for
Pancreatic Ductal Adenocarcinoma, Gastric Cancer,
Location: Kansas City KS, Omaha NE, St Louis MO, Rochester MN,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06710756
Phase1, Phase2, Recruiting
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
for
Idiopathic Pulmonary Fibrosis
Location: Kansas City KS, Sioux Falls SD, Denison TX, Madison WI,
Sponsor: Cumberland Pharmaceuticals
Sex: All
Age: 40+
Code: NCT05571059
Phase2, Recruiting
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
for
Burns, Skin Graft Complications
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18+
Code: NCT06379724
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
for
Oligometastatic Prostate Cancer (OMPC)
Location: Kansas City KS, Omaha NE, Fayetteville AR,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05939414
Phase3, Recruiting
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Kansas City KS, St Louis MO, Madison WI, Milwaukee WI,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase3, Recruiting
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
for
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Location: Kansas City KS, Minneapolis MN, Charlotte NC, Duarte CA,
Sponsor: PeproMene Bio, Inc.
Sex: All
Age: 18+
Code: NCT05370430
Phase1, Recruiting
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
for
Parkinson's Disease
Location: Kansas City KS, Tulsa OK, Chicago IL, Nashville TN,
Sponsor: Intec Pharma Ltd.
Sex: All
Age: 30 - 70+
Code: NCT02615873
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Kansas City KS, Cordova TN, Plano TX, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07225504
Phase3, Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for
Prostate Cancer
Location: Kansas City KS, Omaha NE, St Louis MO, Iowa City IA,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06855277
Phase3, Recruiting
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
for
Relapsed or Resistant Acute Leukaemias
Location: Fairway KS, Chapel Hill NC, Baltimore MD, Tampa FL
Sponsor: Lin BioScience, Inc
Sex: All
Age: 18 - 70+
Code: NCT05756322
Phase1, Phase2, Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for
Cardiovascular Disease and Lipoprotein(a)
Location: Kansas City KS, Topeka KS, City of Saint Peters MO,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07517263
Phase3, Recruiting
Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well
for
Acute Ischemic Stroke
Location: Kansas City KS, St Louis MO, Chicago IL, Dallas TX,
Sponsor: Amrou Sarraj
Sex: All
Age: 18 - 70+
Code: NCT07115940
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for
Prostate Cancer
Location: Kansas City KS, Omaha NE, St Louis MO, Dallas TX,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06780670
Phase2, Phase3, Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for
Relapsing Multiple Sclerosis
Location: Kansas City KS, St Louis MO, Plano TX, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 40 - 70
Code: NCT06846281
Phase3, Recruiting
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
for
Prostate Cancer, Lower Urinary Tract Symptoms
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18+
Code: NCT03802851
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Kansas City KS, Columbia MO, Springfield MO, Omaha NE,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT03907046
Phase3, Recruiting
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
for
Triple Negative Breast Cancer
Location: Westwood KS, St Louis MO, Germantown TN, Dallas TX,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06926920
Phase1, Phase2, Recruiting
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy